|
|
Re: drugn product degradent
The impurity profile may well differ. Since different impurities may degrade differently there could be different degradation products too both in the API and in the drug product. Regards, Brian Matthews. - The GMP Discussion Group is sponsored by gmp review - see http://www.pharmweb.net/gmp.html |
|
|